Daniel Gordon Kirby - 05 Jun 2025 Form 4 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Role: Chief Commercial Officer
Signature: /s/ Daniel Gordon Kirby
Issuer symbol: IOVA
Transactions as of: 05 Jun 2025
Net transactions value: +$55,200
Form type: 4
Filing time: 06 Jun 2025, 16:05:31 UTC
Previous filing: 12 Feb 2025
Next filing: 12 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kirby Daniel Gordon	Chief Commercial Officer	C/O IOVANCE BIOTHERAPEUTICS, INC., 825 INDUSTRIAL ROAD, SUITE 100, SAN CARLOS	/s/ Daniel Gordon Kirby	06 Jun 2025	0002055001

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IOVA	Common Stock	Purchase	$55,200	+30,000		$1.84	30,000	05 Jun 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares were acquired in the open market during a permitted trading window in accordance with the Issuer's Insider Trading Policy. A copy of the Insider Trading Policy is filed as Exhibit 19.1 to the Issuer's Annual Report on Form 10-K for the year ended December 31, 2024.